Centene Corporation Reports 2011 First Quarter Earnings

ST. LOUIS, April 26, 2011 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended March 31, 2011.  The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

First Quarter Highlights

  • Quarter-end managed care at-risk membership of 1,542,500, an increase of 71,200 members, or 4.8% year over year.
  • Premium and Service Revenues of $1.2 billion, representing 15.4% year over year growth.
  • Health Benefits Ratio of 83.0%, compared to 84.0% in the prior year.  
  • General and Administrative expense ratio of 13.8%, compared to 13.3% in the prior year.
  • Cash flow from operations of $94.0 million, or 4.1 times net earnings.
  • Diluted earnings per share from continuing operations of $0.46 (which does not include earnings of $0.07 per diluted share as a result of the delay in the recognition of our Mississippi contract discussed below), compared to $0.41 in the prior year.

 

In January 2011, we began operating in Mississippi through the Mississippi Coordinated Access Network (MississippiCan) program, serving 33,100 members at March 31, 2011.  While the plan has been operating since January 1, 2011 and we have received monthly premium payments and paid claims, the contract remains subject to CMS approval.  Accordingly, we did not recognize revenue of $54.5 million and associated medical costs, which delayed the recognition of earnings of approximately $0.07 per diluted share.  General and administrative expenses related to the Mississippi operations were recognized in our consolidated statement of operations. Upon CMS approval, the revenues, medical costs and related earnings from our Mississippi operations will be recognized in our consolidated statement of operations in the period final approval is obtained, retroactive to January 1, 2011.

 

Other Events

  • In February 2011, we began operating under an agreement with Pima Health Systems in Arizona to administer their long-term care program on a non-risk basis.
  • In February 2011, Superior HealthPlan began operating under an additional STAR+PLUS ABD contract in Texas in the Dallas service area.
  • In March 2011, Standard & Poor's raised its counterparty credit and senior unsecured debt ratings on Centene Corporation to BB from BB-.
  • In April 2011, CeltiCare Health Plan of Massachusetts, Inc. announced the renewal of its contract with the Commonwealth of Massachusetts to serve Commonwealth Care members, effective July 1, 2011.  CeltiCare will continue to be one of the lowest-cost health plan options for low-income, working adults (up to 300% of the federal poverty level) enrolled in the Commonwealth Care program.

 

Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "Our continued focus on fundamentals and enhanced systems capabilities drove solid first quarter performance and a favorable start in a year of opportunity."

 

The following table depicts membership in Centene's managed care organizations, by state, at March 31, 2011 and 2010:

   
   

March 31,

 
   

2011

 

2010

 

Arizona

 

22,600

 

21,700

 

Florida

 

188,800

 

105,900

 

Georgia

 

303,300

 

301,000

 

Indiana

 

209,400

 

211,400

 

Massachusetts

 

34,100

 

26,900

 

Ohio

 

160,900

 

156,000

 

South Carolina

 

84,900

 

53,900

 

Texas

 

456,700

 

459,600

 

Wisconsin

 

81,800

 

134,900

 

Total at-risk membership (1)

 

1,542,500

 

1,471,300

 

Non-risk membership

 

10,400

 

62,200

 

Total

 

1,552,900

 

1,533,500

 
   
         

 

(1)In January 2011, we began operating in Mississippi through the Mississippi Coordinated Access Network (MississippiCan) program, serving 33,100 members at March 31, 2011.  While the plan has been operating since January 1, 2011 and we have received monthly premium payments and paid claims, the contract remains subject to CMS approval.  

 
 

 

The following table depicts membership in Centene's managed care organizations, by member category, at March 31, 2011 and 2010:

   
   

March 31,

 
   

2011

 

2010

 

Medicaid

 

1,169,700

 

1,088,300

 

CHIP & Foster Care

 

208,900

 

266,300

 

ABD & Medicare

 

123,800

 

87,100

 

Hybrid Programs

 

35,200

 

26,900

 

Long-term Care

 

4,900

 

2,700

 

Total at-risk membership

 

1,542,500

 

1,471,300

 

Non-risk membership

 

10,400

 

62,200

 

Total

 

1,552,900

 

1,533,500

 
   
         

 

Statement of Operations: Three Months Ended March 31, 2011

  • For the first quarter of 2011, Premium and Service Revenues increased 15.4% to $1,179.2 million from $1,022.2 million in the first quarter of 2010.  The increase was primarily driven by membership growth resulting from acquisitions in Florida and South Carolina, conversion of membership in Florida from Access to at-risk under Sunshine State Health Plan, as well as premium rate increases.
  • Consolidated HBR of 83.0% for the first quarter of 2011 represents a decrease of 1.0% from the comparable period in 2010.  The year over year improvement in HBR is due to rate increases and lower utilization levels in 2011.  Consolidated HBR decreased 0.3% sequentially from the fourth quarter of 2010.  
  • Consolidated G&A expense as a percent of premium and service revenues was 13.8% in the first quarter of 2011, an increase from 13.3% in the first quarter of 2010.  The 2011 G&A ratio reflects an increase of 0.6% as a result of including general and administrative expenses for Mississippi but not recording the Mississippi premium revenue discussed above.
  • Earnings from continuing operations increased to $39.1 million in 2011 from $29.6 million in 2010, or 32.0% year over year.  Net earnings from continuing operations were $23.7 million, or $0.46 per diluted share in 2011, compared to $20.1 million, or $0.41 per diluted share in the first quarter of 2010.  

 

Balance Sheet and Cash Flow

 

At March 31, 2011, the Company had cash and investments of $1,128.0 million, including $1,096.3 million held by its regulated entities and $31.7 million held by its unregulated entities.  Medical claims liabilities totaled $471.7 million, representing 44.4 days in claims payable.  Total debt was $305.4 million and debt to capitalization was 21.4% at March 31, 2011 excluding the $79.6 million non-recourse mortgage note.  Cash flows from operations were $94.0 million, or 4.1 times net earnings.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:

   

Days in claims payable, December 31, 2010

45.6

   

  Reduced time of claims processing and payment

(0.6)

   

  Reduced utilization

(0.3)

   

  Pharmacy

(0.3)

   

Days in claims payable, March 31, 2011

44.4

   
   
   
     

 

During the first quarter of 2011, we continued to experience increased electronic claims submissions and auto-adjudication of claims which reduced the average time from claims incurred to claims paid by 0.6 days.  Reduced utilization and the related absence of claims payable due to average completion time decreased days in claims payable by 0.3 days.  Days in claims payable was also reduced by 0.3 days as a result of the timing of pharmacy claims payments.  As we continue to experience increasing claims auto-adjudication (5% increase from the fourth quarter 2010 to the first quarter 2011) and EDI submission rates, our targeted range for days in claims payable is under review.

Outlook

The table below depicts the Company's annual guidance from continuing operations for 2011:

   
   

Full Year 2011

   
   

Low

 

High 

   

Premium and Service Revenues (in millions)

 

$   4,900

 

$  5,100

   

Diluted EPS

 

$    2.03

 

$  2.13

   

Consolidated HBR

 

83.5% 

 

84.5% 

   

General & Administrative expense ratio

 

12.4% 

 

12.9% 

   
             

Diluted Shares Outstanding (in thousands)

 

52,000

   
             
   
           

 

Conference Call

As previously announced, the Company will host a conference call Tuesday, April 26, 2011, at 8:30 A.M. (Eastern Time) to review the financial results for the first quarter ended March 31, 2011, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  Investors and other interested parties are invited to listen to the conference call by dialing 1-800-860-2442 in the U.S. and Canada; +1-412-858-4600 from abroad, or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months until 11:59 PM (Eastern Time) on Tuesday, April 24, 2012, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, May 4, 2011, by dialing 1-877-344-7529 the U.S. and Canada, or +1-412-317-0088 from abroad, and entering access code 449378.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.  

(Tables Follow)

 
 

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

 
   

March 31,

2011

 

December 31,

2010

   

ASSETS

             

Current assets:

             

Cash and cash equivalents of continuing operations

 

$

492,045

$

433,914

   

Cash and cash equivalents of discontinued operations

   

 

252

   

Total cash and cash equivalents

   

492,045

 

434,166

   

Premium and related receivables, net of allowance for uncollectible accounts of $17 and $17, respectively

   

132,023

 

136,243

   

Short-term investments, at fair value (amortized cost $51,950 and $21,141, respectively)

   

52,699

 

21,346

   

Other current assets

   

67,062

 

64,154

   

Current assets of discontinued operations other than cash

   

 

912

   

Total current assets

   

743,829

 

656,821

   

Long-term investments, at fair value (amortized cost $548,013 and $585,862, respectively)

   

556,806

 

595,879

   

Restricted deposits, at fair value (amortized cost $26,502 and $22,755, respectively)

   

26,482

 

22,758

   

Property, software and equipment, net of accumulated depreciation of $148,051 and $138,629, respectively

   

334,180

 

326,341

   

Goodwill

   

278,105

 

278,051

   

Intangible assets, net

   

27,813

 

29,109

   

Other long-term assets

   

36,470

 

30,057

   

Long-term assets of discontinued operations

   

 

4,866

   

Total assets

 

$

2,003,685

$

1,943,882

   
               

Current liabilities:

             

Medical claims liability

 

$

471,659

$

456,765

   

Accounts payable and accrued expenses

   

214,900

 

185,218

   

Unearned revenue

   

127,451

 

117,344

   

Current portion of long-term debt

   

3,037

 

2,817

   

Current liabilities of discontinued operations

   

 

3,102

   

Total current liabilities

   

817,047

 

765,246

   

Long-term debt

   

302,326

 

327,824

   

Other long-term liabilities

   

53,116

 

53,378

   

Long-term liabilities of discontinued operations

   

 

379

   

Total liabilities

   

1,172,489

 

1,146,827

   
               

Commitments and contingencies

             
               

Stockholders' equity:

             

Common stock, $.001 par value; authorized 100,000,000 shares; 52,533,873 issued and 49,965,357 outstanding at March 31, 2011, and 52,172,037 issued and 49,616,824 outstanding at December 31, 2010

   

53

 

52

   

Additional paid-in capital

   

396,380

 

384,206

   

Accumulated other comprehensive income:

             

Unrealized gain on investments, net of tax

   

5,969

 

6,424

   

Retained earnings

   

477,488

 

453,743

   

Treasury stock, at cost (2,568,516 and 2,555,213 shares, respectively)

   

(50,888)

 

(50,486)

   

Total Centene stockholders' equity

   

829,002

 

793,939

   

Noncontrolling interest

   

2,194

 

3,116

   

Total stockholders' equity

   

831,196

 

797,055

   

Total liabilities and stockholders' equity

 

$

2,003,685

$

1,943,882

   
   
             

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share data)

(Unaudited)

 
 

Three Months Ended

March 31,

   
 

2011

   

2010

   

Revenues:

               

Premium

$

1,152,777

   

$

999,315

   

Service

 

26,384

     

22,907

   

   Premium and service revenues

 

1,179,161

     

1,022,222

   

Premium tax

 

37,196

     

46,499

   

Total revenues

 

1,216,357

     

1,068,721

   

Expenses:

               

Medical costs

 

957,074

     

839,708

   

Cost of services

 

20,176

     

17,152

   

General and administrative expenses

 

162,581

     

135,507

   

Premium tax

 

37,429

     

46,743

   

Total operating expenses

 

1,177,260

     

1,039,110

   

Earnings from operations

 

39,097

     

29,611

   

Other income (expense):

               

Investment and other income

 

3,749

     

7,057

   

Interest expense

 

(5,695 )

     

(3,813 )

   

Earnings from continuing operations, before income tax expense

 

37,151

     

32,855

   

Income tax expense

 

14,328

     

12,525

   

Earnings from continuing operations, net of income tax expense

 

22,823

     

20,330

   

Discontinued operations, net of income tax expense of $0 and $4,440, respectively

 

     

3,920

   

Net earnings

 

22,823

     

24,250

   

Noncontrolling interest

 

(922 )

     

248

   

Net earnings attributable to Centene Corporation

$

23,745

   

$

24,002

   
                 

Amounts attributable to Centene Corporation common shareholders:

               

Earnings from continuing operations, net of income tax expense

$

23,745

   

$

20,082

   

Discontinued operations, net of income tax expense

 

     

3,920

   

Net earnings

$

23,745

   

$

24,002

   
                 

Net earnings per share attributable to Centene Corporation:

               

Basic:

               

   Continuing operations

$

0.48

   

$

0.43

   

   Discontinued operations

 

     

0.08

   

   Earnings per common share

$

0.48

   

$

0.51

   

Diluted:

               

   Continuing operations

$

0.46

   

$

0.41

   

   Discontinued operations

 

     

0.08

   

   Earnings per common share

$

0.46

   

$

0.49

   
                 

Weighted average number of shares outstanding:

               

   Basic

 

49,750,430

     

47,260,714

   

   Diluted

 

51,811,721

     

48,761,528

   
   
               

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 
 

Three Months Ended   March 31,

   
 

2011

 

2010

   
               

Cash flows from operating activities:

             

Net earnings

$

22,823

 

$

24,250

   

Adjustments to reconcile net earnings to net cash provided by operating activities

             

   Depreciation and amortization

 

14,325

   

12,527

   

   Stock compensation expense

 

4,394

   

3,460

   

   Gain on sale of investments, net

 

(118 )

   

(3,547 )

   

   Gain on sale of UHP

 

   

(8,201 )

   

   Deferred income taxes

 

(700 )

   

950

   

Changes in assets and liabilities

             

   Premium and related receivables

 

4,216

   

(4,457 )

   

   Other current assets

 

(1,636 )

   

(1,375 )

   

   Other assets

 

151

   

1,937

   

   Medical claims liabilities

 

13,430

   

(33,129 )

   

   Unearned revenue

 

10,106

   

(73,282 )

   

   Accounts payable and accrued expenses

 

26,268

   

40,433

   

   Other operating activities

 

732

   

1,934

   

Net cash provided by (used in) operating activities

 

93,991

   

(38,500 )

   

Cash flows from investing activities:

             

   Capital expenditures

 

(15,725 )

   

(12,520 )

   

   Capital expenditures of Centene Center LLC

 

(1,157 )

   

(10,579 )

   

   Purchases of investments

 

(40,423 )

   

(146,935 )

   

   Proceeds from asset sales

 

   

13,420

   

   Sales and maturities of investments

 

45,327

   

117,469

   

   Investments in acquisitions, net of cash acquired

 

   

(2,019 )

   

Net cash used in investing activities

 

(11,978 )

   

(41,164 )

   

Cash flows from financing activities:

             

   Proceeds from exercise of stock options

 

6,518

   

519

   

   Proceeds from borrowings

 

127,300

   

22,030

   

   Proceeds from stock offering

 

   

104,557

   

   Payment of long-term debt

 

(152,577 )

   

(97,136 )

   

   Distributions to noncontrolling interest

 

   

(3,585 )

   

   Excess tax benefits from stock compensation

 

1,132

   

96

   

   Common stock repurchases

 

(402 )

   

(480 )

   

   Debt issue costs

 

(6,105 )

   

   

Net cash (used in) provided by financing activities

 

(24,134 )

   

26,001

   

Net increase (decrease) in cash and cash equivalents

 

57,879

   

(53,663 )

   

Cash and cash equivalents, beginning of period

 

434,166

   

403,752

   

Cash and cash equivalents, end of period

$

492,045

 

$

350,089

   
               

Supplemental disclosures of cash flow information:

             

   Interest paid

$

1,714

 

$

345

   

   Income taxes paid

$

9,567

 

$

8,272

   
               

Supplemental disclosure of non-cash investing and financing activities:

             

   Contribution from noncontrolling interest

$

 

$

306

   

   Capital expenditures

$

1,477

 

$

789

   
   
             

 

CENTENE CORPORATION

 

CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA

 
 

Q1

 

Q4

 

Q3

 

Q2

 

Q1

 
 

2011

 

2010

 

2010

 

2010

 

2010

 

MEMBERSHIP

                   

Managed Care:

                   

Arizona                           

22,600

 

22,400

 

22,300

 

22,100

 

21,700

 

Florida                            

188,800

 

194,900

 

116,300

 

113,100

 

105,900

 

Georgia                           

303,300

 

305,800

 

300,900

 

295,600

 

301,000

 

Indiana                            

209,400

 

215,800

 

213,300

 

212,700

 

211,400

 

Massachusetts                     

34,100

 

36,200

 

34,400

 

30,100

 

26,900

 

Ohio                              

160,900

 

160,100

 

161,800

 

159,300

 

156,000

 

South Carolina                      

84,900

 

90,300

 

90,600

 

92,600

 

53,900

 

Texas                             

456,700

 

433,100

 

428,100

 

475,500

 

459,600

 

Wisconsin                         

81,800

 

74,900

 

106,100

 

133,600

 

134,900

 

Total at-risk membership (a)     

1,542,500

 

1,533,500

 

1,473,800

 

1,534,600

 

1,471,300

 

Non-risk membership                 

10,400

 

4,200

 

35,900

 

50,900

 

62,200

 

TOTAL                     

1,552,900

 

1,537,700

 

1,509,700

 

1,585,500

 

1,533,500

 
                     

(a) In January 2011, we began operating in Mississippi through the Mississippi Coordinated Access Network (MississippiCan) program, serving 33,100 members at March 31, 2011.  While the plan has been operating since January 1, 2011 and we have received monthly premium payments and paid claims, the contract remains subject to CMS approval.  

 
                     

Medicaid                           

1,169,700

 

1,177,100

 

1,122,800

 

1,135,500

 

1,088,300

 

CHIP & Foster Care                  

208,900

 

210,500

 

219,100

 

272,400

 

266,300

 

ABD & Medicare                     

123,800

 

104,600

 

94,500

 

93,800

 

87,100

 

Hybrid Programs                    

35,200

 

36,200

 

34,400

 

30,100

 

26,900

 

Long-term Care                     

4,900

 

5,100

 

3,000

 

2,800

 

2,700

 

Total at-risk membership        

1,542,500

 

1,533,500

 

1,473,800

 

1,534,600

 

1,471,300

 

Non-risk membership                 

10,400

 

4,200

 

35,900

 

50,900

 

62,200

 

TOTAL                     

1,552,900

 

1,537,700

 

1,509,700

 

1,585,500

 

1,533,500

 
                     

Specialty Services(b):

                   

Cenpatico Behavioral Health

                   

Arizona                           

172,700

 

174,600

 

121,300

 

119,700

 

119,300

 

Kansas                           

44,000

 

39,200

 

39,800

 

39,100

 

39,800

 

TOTAL                     

216,700

 

213,800

 

161,100

 

158,800

 

159,100

 
                     

(b) Includes external membership only.

                 
                     

REVENUE PER MEMBER PER MONTH(c)

$

238.31

 

$

239.66

 

$

224.62

 

$

218.40

 

$

219.90

 
                     

CLAIMS(c)

                   

Period-end inventory                 

527,100

 

434,900

 

469,000

 

480,400

 

341,400

 

Average inventory                  

347,900

 

304,700

 

307,500

 

306,900

 

283,900

 

Period-end inventory per member       

0.34

 

0.28

 

0.32

 

0.31

 

0.23

 

(c) Revenue per member and claims information are presented for the Managed Care at-risk members.

 
   
                             

 
   
 

Q1

 

Q4

 

Q3

 

Q2

 

Q1

 
 

2011

 

2010

 

2010

 

2010

 

2010

 
                     

DAYS IN CLAIMS PAYABLE

44.4

 

45.6

 

47.1

 

48.2

 

47.7

 

Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.

 
                     

CASH AND INVESTMENTS (in millions)

                 

   Regulated                           

$

1,096.3

 

$

1,043.0

 

$

895.4

 

$

813.0

 

$

917.9

 

   Unregulated                         

 

31.7

   

30.9

   

32.7

   

39.4

   

51.3

 

       TOTAL                           

$

1,128.0

 

$

1,073.9

 

$

928.1

 

$

852.4

 

$

969.2

 
                     

DEBT TO CAPITALIZATION

26.9%

 

29.3%

 

24.7%

 

24.5%

 

23.7%

 

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT(d)

21.4%

 

23.9%

             

Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).  

(d) The non-recourse debt represents our mortgage note payable of $79.6 million at March 31, 2011 and $80.0 million at December 31, 2010.

 
   
                             

 

OPERATING RATIOS:

 
 

Three Months Ended March 31,

 
 

2011

   

2010

 

Health Benefits Ratios:

             

   Medicaid and CHIP

82.4

%

   

85.6

%

 

   ABD and Medicare

85.1

     

80.3

   

   Specialty Services

82.7

     

80.6

   

   Total

83.0

     

84.0

   
               

Total General & Administrative Expense Ratio

13.8

%

   

13.3

%

 
   
             

 

MEDICAL CLAIMS LIABILITY (In thousands)

The changes in medical claims liability are summarized as follows:

 
         

Balance, March 31, 2010

$

444,826

   

Incurred related to:

       

Current period

 

3,697,199

   

Prior period

 

(65,439)

   

Total incurred

 

3,631,760

   

Paid related to:

       

Current period

 

3,234,366

   

Prior period

 

370,561

   

Total paid

 

3,604,927

   

Balance, March 31, 2011

$

471,659

   
   
       

 

Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to:  Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

The amount of the "Incurred related to: Prior period" above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to March 31, 2010.

SOURCE Centene Corporation